The fight against COVID19
23.82k followers • 14 symbols Watchlist by TREA
Follow this list to discover and track the stock of publicly traded companies with COVID-19 related treatment and healthcare plans.
Curated by TREA
TREA analyses over 100 million data points, interactions, relationships on company research and development activities, allowing investors to quickly gain insight without having to go through complex regulatory filings. Primary data sources include: US FDA (US Food and Drug Administration), US NIH (US National Institutes of Health), USPTO (US Patent and Trademark Office). The search parameters for generating this watchlist were (1) Above sector average Innovation Index score, (2) IP history of at least 5 years (3) COVID19 (4) 2019-nCov (5) SARS-CoV-2, among others.
Performance
| Watchlist | Change today | 1-month return | 1-year return | Total return |
|---|---|---|---|---|
| The fight against COVID19 | -1.11% | - | - | - |
| ^GSPC | +0.12% | +5.83% | +26.33% | +5602.44% |
14 symbols
| Symbol | Company name | Last price | Change | % change | Market time | Volume | Avg vol (3-month) | Market cap |
|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 154.64 | +0.36 | +0.23% | 4:00 pm GMT-4 | 6.09M | 7.46M | 372.17B |
| ABBV | AbbVie Inc. | 166.42 | +2.07 | +1.26% | 4:00 pm GMT-4 | 4.95M | 5.61M | 293.88B |
| PFE | Pfizer Inc. | 28.64 | -0.28 | -0.97% | 4:01 pm GMT-4 | 25.66M | 42.47M | 162.29B |
| SNY | Sanofi | 48.67 | -0.15 | -0.31% | 4:00 pm GMT-4 | 613.41k | 1.99M | 122.80B |
| REGN | Regeneron Pharmaceuticals, Inc. | 982.29 | +14.31 | +1.48% | 4:00 pm GMT-4 | 386.46k | 455.40k | 108.23B |
| GSK | GSK plc | 44.98 | +0.10 | +0.22% | 4:00 pm GMT-4 | 1.87M | 3.15M | 93.80B |
| GILD | Gilead Sciences, Inc. | 67.72 | -0.14 | -0.21% | 4:00 pm GMT-4 | 3.57M | 6.97M | 84.37B |
| MRNA | Moderna, Inc. | 132.9 | +0.22 | +0.17% | 4:00 pm GMT-4 | 2.70M | 3.82M | 50.93B |
| TAK | Takeda Pharmaceutical Company Limited | 13.22 | -0.09 | -0.68% | 4:00 pm GMT-4 | 1.01M | 1.65M | 41.70B |
| BNTX | BioNTech SE | 90.61 | -2.37 | -2.55% | 4:00 pm GMT-4 | 471.65k | 591.09k | 21.84B |
| NVAX | Novavax, Inc. | 13.01 | -1.39 | -9.65% | 4:00 pm GMT-4 | 13.76M | 12.78M | 1.92B |
| VIR | Vir Biotechnology, Inc. | 9.73 | -0.20 | -2.01% | 4:00 pm GMT-4 | 624.61k | 988.40k | 1.32B |
| INO | Inovio Pharmaceuticals, Inc. | 12 | -0.79 | -6.18% | 4:00 pm GMT-4 | 414.23k | 443.72k | 310.93M |
- Thomson Reuters StreetEvents
Q1 2024 Autolus Therapeutics PLC Earnings Call
Q1 2024 Autolus Therapeutics PLC Earnings Call
TipRanksDoes AI Really Make Moderna Stock (NASDAQ:MRNA) a Buy?
Moderna (NASDAQ:MRNA) stock has collapsed from its all-time high. However, the company is once again on the move — in a good way. The stock is up 68% over the past six months, with partnerships around artificial intelligence (AI) and positive cancer trial data garnering investor interest. Personally, though, I’m still unconvinced that these developments make MRNA stock a buy and require more data before I make a decision. For now, I remain neutral. MRNA stock has fallen significantly from its al
Sign in to view your followed lists
© 2024 Yahoo. All rights reserved.